For your skin
The "calm-down" molecule in many sensitive-skin formulas. Reduces redness and stinging without bleaching your barrier, and plays nicely on top of retinoids or exfoliating acids.
Want the science? Keep reading ↓Mechanism of action
Chamomile-derived sesquiterpene alcohol that suppresses TNF-α and IL-6 in keratinocytes and macrophages and dampens TPA-induced skin inflammation in dose-dependent fashion.
Why we tier this moderate
5 cited papers across 3 countries. The mechanism is well-described and there's at least one controlled trial in the literature, but we tier this Moderate rather than Strong to stay honest about how many specific papers we cite directly.
Cited research
Wu Y et al., Exploring the mechanism of alpha-Bisabolol in the treatment of psoriasis based on network pharmacology and experimental validation, European Journal of Pharmacology 2025 — alpha-bisabolol suppressed inflammation in TNF-alpha-treated keratinocytes and psoriasis mice via PI3K/AKT and NF-kB pathways; reduced IL-6, IL-1beta, TNF-alpha and skin lesions
Karami H et al. (Brazil), Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model, International Journal of Pharmaceutics 2024
Tan C et al. (Brazil), The combination of allantoin, bisabolol, D-panthenol and dipotassium glycyrrhizinate mitigates UVB-induced PGE2 synthesis by keratinocytes, International Journal of Cosmetic Science 2024
Werner R et al. (Germany), Determination of the Influence of the Antiphlogistic Ingredients Panthenol and Bisabolol on the SPF Value in vivo, Skin Pharmacology and Physiology 2017;30(4) — in vivo SPF + erythema study confirmed bisabolol does not suppress erythema response (no false-positive SPF inflation) while remaining a recognized antiphlogistic active
Maurya AK et al. (India), alpha-(-)-Bisabolol reduces pro-inflammatory cytokine production and ameliorates skin inflammation, Current Pharmaceutical Biotechnology 2014;15(2):173-181
Sources: PubMed · KCI · J-Stage · CNKI · Wanfang · SFD · MFDS · Cochrane · SCCS · CIR. Every entry points to a specific document. See methodology for what each outcome label means.